JPRN-UMIN000003276已完成未知
Aggressive lipid-lowering treatment approaches for vulnerable plaque in coronary artery with rosuvastatin. -Assessment using angioscopy and intravascular ultrasound - - ALTAIR Study
ALTAIR Study0 个研究点目标入组 50 人开始时间: 2010年3月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients whose onset of acute coronary syndrome is <= 24 h 2) Patients who will require bypass surgery <= 48 h 3) Patients with familial hypercholesterolemia or secondary hypercholesterolemia 4) Patients whose fasting serum is TG >= 400 mg/dL 5) Patients with a history of hypersensitivity to statins 6) Patients with serious diabetes mellitus (HbA1c >= 8.5%) 7) Patients with active liver disease (ALT or AST: > 100 IU/L, total bilirubin: > 2.5 mg/dL) 8) Patients with renal impairment (serum Cr >= 2.0 mg/dL or Ccr < 30 mL/min [Cockcroft-Gault formula]) 9) Patients receiving ciclosporin treatment 10) Patients who are, or who may possibly be, pregnant 11) Patients with hypothyroidism, genetic muscular disorder (e.g., muscular dystrophy) or a family history thereof, patients with a history of drug-related muscular disorders 12) Patients who are drug abusers or alcoholics 13) Other patients whom the investigator considers unsuitable for inclusion in the study
研究者
相似试验
已完成
不适用
Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound StudyAcute Coronary SyndromeJPRN-UMIN000003620Hyogo College of Medicine Cardiovascular Division50
招募中
不适用
Examination of the optimal lipid-lowering therapy in patients with type 2 diabetes complicated with dyslipidemiatype 2 diabetes complicated with dyslipidemiaJPRN-UMIN000006537Department of Endocrinology and Metabolism Kyoto Prefectural University of Medicine, Graduate School of Medical Science30
招募中
Unknown
Impact of Aggressive Lipid-Lowering Therapy with Evolocumab on Peripheral Atherosclerotic Plaque Assessed with NIRS-IVUS in Patients with Peripheral Artery DiseasePeripheral artery diseaseJPRN-UMIN000049231niversity of Fukui Division of Cardiovascular Medicine, Faculty of Medical Sciences30
已完成
不适用
The effecs of intensive lipid-lowering therapy on the progression of atherosclerotic kidney diseasechronic kidney diseaseJPRN-UMIN000021356niversity, School of Medicine40
已完成
不适用
Clinical trials of the lipid improvement effect of Goishi tea evaluated by index LDL cholesterolHealthy individualJPRN-UMIN000024028Kochi medical school hospital80